Janux Therapeutics, Inc. (JANX) Financials

JANX Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 386.9 million 37.9 million
2023-06-30 341.5 million 42.0 million
2023-03-31 353.0 million 41.7 million
2022-12-31 364.0 million 43.3 million

JANX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -12.2 million 4.5 million
2023-06-30 -15.6 million 5.5 million
2023-03-31 -14.2 million 5.5 million
2022-12-31 -14.0 million 4.2 million

JANX Net Income

No data available :(

JANX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 349.7 million - 24.9 million
2023-06-30 303.3 million - 25.2 million
2023-03-31 316.9 million - 25.5 million
2022-12-31 327.0 million - 25.3 million

JANX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 45.7 million
2023-06-30 41.8 million
2023-03-31 41.8 million
2022-12-31 41.6 million

JANX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 470000 11.9 million 6.4 million -
2023-06-30 580000 14.9 million 6.9 million -
2023-03-31 285000 15.9 million 6.5 million -
2022-12-31 2.1 million 15.4 million 5.7 million -

JANX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 2.5 million 500000
2023-06-30 1.1 million 471000
2023-03-31 2.0 million 453000
2022-12-31 2.8 million 403000

JANX

Price: $64.78

52 week price:
5.65
64.78

Earnings Per Share: -1.32 USD

P/E Ratio: -5.66

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 219876

Market Capitalization: 2.1 billion

Links: